Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Salivary Gland Neoplasms × Granulocyte Colony-Stimulating Factor × Clear all

Sponsor

Conditions

Multiple Myeloma 45 Leukemia, Myeloid, Acute 39 Lymphoma, Non-Hodgkin 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 32 Lymphoma 31 Hodgkin Disease 30 Myelodysplastic Syndromes 26 Leukemia 26 Lymphoma, Mantle-Cell 19 Leukemia, Lymphocytic, Chronic, B-Cell 18 Lymphoma, Large B-Cell, Diffuse 17 Burkitt Lymphoma 15 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14 Lymphoma, Follicular 12 Lymphoma, B-Cell, Marginal Zone 10 Hematologic Neoplasms 10 Neoplasms, Plasma Cell 9 Leukemia, Biphenotypic, Acute 9 Congenital Abnormalities 9 Breast Neoplasms 9 Lymphoma, Large-Cell, Immunoblastic 8 Recurrence 7 Leukemia, Myelomonocytic, Juvenile 7 Leukemia, Myelomonocytic, Chronic 7 Anemia, Refractory, with Excess of Blasts 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Neuroblastoma 6 Myeloproliferative Disorders 6 Sarcoma 5 Primary Myelofibrosis 5

Interventions

Cetuximab 3 Vorinostat 2 Radiosurgery 2 Nivolumab 2 Ipilimumab 2 Dasatinib 2 Cisplatin 2 Bevacizumab 2 temsirolimus 1 pembrolizumab 1 ispinesib 1 eribulin 1 dehydroftorafur 1 apalutamide 1 alectinib 1 Sorafenib 1 Sirolimus 1 Platinum 1 Pilocarpine 1 Oral Hygiene 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Moxibustion 1 Magnetic Resonance Spectroscopy 1 MK 2206 1 Lapatinib 1 Irinotecan 1 Immunoglobulin G 1 Gonadotropin-Releasing Hormone 1 Gemcitabine 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡